Search Within

David H Ilson

  1. "MSK Grad Students"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (16)
  2. Epidemiology and Biostatistics (16)
  3. Gastrointestinal Oncology Service (16)
  4. Hematologic Malignancies, Division of (16)
  5. MSK Grad Students (16)
  6. Solid Tumor Oncology Division (16)

More Groups

People
  1. Geoffrey Ku (16)
  2. Nikolaus Schultz (15)
  3. Walid Chatila (15)
  4. Yelena Janjigian (15)
  5. David Solit (10)
  6. Laura Tang (10)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Clinical Cancer Research (4)
  3. Annals of Surgery (1)
  4. Cancer (1)
  5. Cancer Discovery (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (5)
  3. Elsevier Science, Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Survival of locally advanced MSI-high gastric cancer patients treated with perioperative chemotherapy: A retrospective cohort study
    Journal Article

    Vos, E. L.; Maron, S. B.; Krell, R. W.; Nakauchi, M.; Fiasconaro, M.; Capanu, M.; Walch, H. S.; Chatila, W. K.; Schultz, N.; Ilson, D. H.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Differences in genomic profiles of gastric adenocarcinoma in the US and Japan
    Meeting Abstract

    Nakauchi, M.; Court, C.; Walsh, H. S.; Chatila, W. K.; Shimada, S.; Vardhana, S.; Tang, L. H.; Coit, D. G.; Janjigian, Y. Y.; Maron, S. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
    Journal Article

    Yu, K. H.; Park, J.; Mittal, A.; Abou-Alfa, G. K.; El Dika, I.; Epstein, A. S.; Ilson, D. H.; Kelsen, D. P.; Ku, G. Y.; Li, J.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save